PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”

2026-01-09
(Press-News.org)

Background

Most of us know the feeling: maybe it is making a difficult phone call, starting a report you fear will be criticized, or preparing a presentation that’s stressful just to think about. You understand what needs to be done, yet taking that very first step feels surprisingly hard. When this difficulty becomes severe, it is known medically as avolition. People with avolition are not lazy or unaware: they know what they need to do, but their brain seems unable to push the "go" button. Avolition is commonly seen in conditions such as depression, schizophrenia, and Parkinson's disease, and it seriously disrupts a person’s ability to manage daily life and maintain social functions.

Research in neuroscience and psychology has suggested that before we act, the brain weighs how much effort a task may cost. If the cost feels too high, motivation drops. But until now, it has been unclear how the brain turns this judgment into a decision not to act. To explore this question, a research team at WPI-ASHBi applied an advanced genetic technique called chemogenetics to highly intelligent macaque monkeys, allowing them to adjust communication temporarily and precisely between specific brain regions and identify a circuit that acts like a brake on motivation.

Methods and key findings

The monkeys were trained to perform two types of tasks. In one, completing the task earned a water reward. In the other, the reward came with an added downside: an unpleasant air puff to the face. Before each trial, the monkeys saw a cue and could freely decide whether to start or not. The researchers focused not on which option the monkeys chose, but on something more fundamental: did they take the first step at all? As expected, when the task involved only a reward, the monkeys usually got started without hesitation. But when the task involved an unpleasant air puff, they often held back, even though a reward was still available.

The researchers then temporarily weakened a specific brain connection linking two regions involved in motivation: the ventral striatum (VS) and the ventral pallidum (VP). In the reward-only task, suppressing this pathway had little effect on monkey behavior, and the monkeys initiated the task normally. In contrast, in tasks involving an unpleasant air puff, the mental brake to starting had eased: the monkeys became much more willing to start. Importantly, the monkeys' ability to judge rewards and punishments did not change. What changed was the step between knowing and doing.

The researchers took a closer look at what was actually happening in these brain regions during this process. Neural activity in the VS increased during the stressful task, suggesting it helps the brain register when a situation feels stressful. In contrast, activity in the VP gradually fell as the monkeys became less willing to start the task, showing that these two regions play different roles. Together, these findings show that the VS to VP pathway functions as a "motivation brake" that suppresses the internal "go" button, particularly when facing stressful or unpleasant tasks.

Future perspectives

This discovery of the VS–VP “motivation brake” may shed light on conditions such as depression and schizophrenia, where severe loss of motivation is common. In the future, interventions such as deep brain stimulation, non-invasive brain stimulation, or new drug strategies might aim to fine-tune this brake when it becomes too tight. But this “brake” exists for a reason. While an overly tight brake can lead to avolition, a brake that is too loose could make it harder to stop, even in excessively stressful situations, potentially leading to burnout. In other words, the VS–VP circuit may help keep motivation within a healthy range. “Over weakening the motivation brake could lead to dangerous behavior or excessive risk-taking,” said Ken-ichi Amemori, lead author of the study. “Careful validation and ethical discussion will be necessary to determine how and when such interventions should be used.”

In modern society, especially at a time when burnout is at an all-time high, these findings invite us to rethink what “motivation” really means. The brain can actively dampen the drive to act when tasks are unpleasant or stressful, so getting started is not simply about willpower. Rather than trying to forcibly boost motivation, the focus should shift toward how society can better support people in coping with stress. This is a question that warrants broader societal dialogue.

Glossary

Chemogenetics: A method for remotely controlling selected brain cells. Researchers first give specific neurons an artificial “switch” (a receptor) using a gene-delivery tool. They can then turn those neurons up or down for a short time by giving a drug that only works on that switch, letting them test the role of a particular circuit. Ventral striatum (VS): A brain region involved in reward, motivation, and learning. Part of it is also called the nucleus accumbens. Ventral pallidum (VP): A brain region that receives signals from the ventral striatum and helps pass them on to other parts of the brain. It is an important hub for turning motivation-related signals into action by relaying and combining information sent to areas such as the thalamus, midbrain, limbic system, and prefrontal cortex. END



ELSE PRESS RELEASES FROM THIS DATE:

Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists

2026-01-09
About The Study: In this single-center cohort study, both bariatric surgery and semaglutide or tirzepatide treatment were associated with substantial fat mass loss, moderate fat-free mass (FFM) loss, and improved FFM to fat mass ratio. These findings provide evidence to guide interventions aimed at preserving FFM while promoting fat loss. Corresponding Authors: To contact the corresponding authors, email Jason M. Samuels, MD, (jason.m.samuels@vumc.org) and Danxia Yu, PhD, (danxia.yu@vumc.org). To access the embargoed study: Visit our For The Media website ...

Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment

2026-01-09
About The Study: The findings of this study suggest an increase in maternal morbidity among patients using fertility care in states that passed targeted regulation of abortion providers (TRAP) laws relative to states that did not. Corresponding Author: To contact the corresponding author, Samuel J. F. Melville, MD, email melvills@ohsu.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2025.5920) Editor’s ...

Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting

2026-01-09
BETHESDA, MD – January 9, 2026 | The American College of Medial Genetics and Genomics (ACMG) announced today that press registration is now open for the  2026 ACMG Annual Clinical Genetics Meeting, taking place in Baltimore, Maryland on March 10-14, 2026. Join us “Where Genetics Meets Innovation” and experience first-hand the transformation of clinical genetics, from primarily a diagnostic field to one increasingly driven by treatment and precision therapeutics. This premier medical and scientific conference brings together leading experts in medical genetics ...

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

2026-01-09
Alzheimer’s disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows sex-based differences, with women being more at risk. However, the origin of these differences remains unknown. While bone morphogenetic proteins (BMPs) play an important role in adult neurogenesis, their role in AD remains elusive. To address this, researchers have investigated sex-based differences and role of BMP signaling in neurogenesis in AD mice models, uncovering novel therapeutic targets. Alzheimer’s disease (AD) is one of the main causes of dementia, characterized by progressive neurodegeneration, typically beginning at or after 65 years ...

Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward

2026-01-09
Under the threat of climate change and geopolitical tensions related to fossil fuels, the world faces an urgent need to find sustainable and renewable energy solutions. While wind, solar, and hydroelectric power are key renewable energy sources, their output strongly depends on environmental conditions, meaning they are unable to provide a stable electricity supply for modern grids. Solid oxide fuel cells (SOFCs), on the other hand, represent a promising alternative; these devices produce electricity on demand directly from clean electrochemical reactions involving hydrogen and oxygen. However, ...

Clues from the past reveal the West Antarctic Ice Sheet’s vulnerability to warming

2026-01-09
The Thwaites and Pine Island glaciers, located in the Amundsen Sea sector of the West Antarctic Ice Sheet (WAIS), are among the fastest-melting glaciers on Earth. Together, they are losing ice more rapidly than any other part of Antarctica, raising serious concerns about the long-term stability of the ice sheet and its contribution to future sea-level rise. To better understand the risks that warmer conditions pose to the WAIS, researchers are looking back to the Pliocene Epoch (5.3–2.58 million years ago), when global temperatures were about 3–4 ...

Collaborative study uncovers unknown causes of blindness

2026-01-09
Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited blindness. Their study shows that changes in specific pieces of DNA, which play a role in processing genetic information, can lead to retinitis pigmentosa. This eye condition affects about 1 in 5,000 people worldwide, causing ‘tunnel vision’ and often leads to legal blindness. The discovery provides clarity for dozens of families globally and opens new possibilities for diagnostics and counseling in hereditary conditions.      Retinitis ...

Inflammatory immune cells predict survival, relapse in multiple myeloma

2026-01-09
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes robust patient outcome data, provides unparalleled new insights into how the immune system interacts with cancerous plasma cells and can be used to determine how aggressive a patient’s multiple myeloma is likely to be. The knowledge may improve survival predictions, guide treatment decisions and help in the development of new immune-based therapies for patients with multiple ...

New test shows which antibiotics actually work

2026-01-09
Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory conditions. A critical factor, however, is whether the active substances actually kill the pathogens in the body. Researchers at the University of Basel have presented a new method for measuring how effectively antibiotics kill bacteria. Antibiotic-resistant bacteria are one of the biggest health problems of our time. Due to mutations, bacteria are increasingly resisting the effects of common drugs, making these infections increasingly difficult to treat. But even ...

Most Alzheimer’s cases linked to variants in a single gene

2026-01-09
Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers. The scientists also found that close to half of all dementia cases would probably not arise without the gene’s influence. The researchers say that the findings, published today in npj Dementia, highlight this gene (and the protein it produces) as a powerful yet under-recognised target for drug development, which could have the scope to prevent or treat a large proportion of all dementia. The APOE gene has long been implicated in Alzheimer’s disease. There are three common ...

LAST 30 PRESS RELEASES:

The vast majority of US rivers lack any protections from human activities, new research finds

Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy

Environmental “superbugs” in our rivers and soils: new one health review warns of growing antimicrobial resistance crisis

Triple threat in greenhouse farming: how heavy metals, microplastics, and antibiotic resistance genes unite to challenge sustainable food production

Earthworms turn manure into a powerful tool against antibiotic resistance

AI turns water into an early warning network for hidden biological pollutants

Hidden hotspots on “green” plastics: biodegradable and conventional plastics shape very different antibiotic resistance risks in river microbiomes

Engineered biochar enzyme system clears toxic phenolic acids and restores pepper seed germination in continuous cropping soils

Retail therapy fail? Online shopping linked to stress, says study

How well-meaning allies can increase stress for marginalized people

Commercially viable biomanufacturing: designer yeast turns sugar into lucrative chemical 3-HP

Control valve discovered in gut’s plumbing system

George Mason University leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Hop to it: research from Shedd Aquarium tracks conch movement to set new conservation guidance

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The Age of Fishes began with mass death

TB harnesses part of immune defense system to cause infection

Important new source of oxidation in the atmosphere found

A tug-of-war explains a decades-old question about how bacteria swim

Strengthened immune defense against cancer

Engineering the development of the pancreas

The Journal of Nuclear Medicine ahead-of-print tip sheet: Jan. 9, 2026

Mount Sinai researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”

Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists

Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment

Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward

Clues from the past reveal the West Antarctic Ice Sheet’s vulnerability to warming

[Press-News.org] Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”